Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.

<h4>Background</h4> <p>We identified anti-obesity medications withdrawn since 1950 because of adverse drug reactions after regulatory approval, and examined the evidence used to support such withdrawals, investigated the mechanisms of the adverse reactions, and explored the trends...

書誌詳細
主要な著者:	Onakpoya, I, Heneghan, C, Aronson, J
フォーマット:	Journal article
言語:	English
出版事項:	BioMed Central 2016

類似資料

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
著者:: Onakpoya, I, 等
出版事項: (2017)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
著者:: Onakpoya, IJ, 等
出版事項: (2016)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
著者:: Onakpoya, I, 等
出版事項: (2016)

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.
著者:: Onakpoya, I, 等
出版事項: (2017)

An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
著者:: Onakpoya, I
出版事項: (2017)

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.
著者:: Onakpoya, I, 等
出版事項: (2017)

Pharmacogenetics and adverse drug reactions
著者:: Ferner, R, 等
出版事項: (2010)

An agenda for research on adverse drug reactions.
著者:: Aronson, J
出版事項: (2007)

Adverse drug reactions--no farewell to harms.
著者:: Aronson, J
出版事項: (2007)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
著者:: Aronson, J
出版事項: (2008)

Adverse drug reactions: definitions, diagnosis, and management.
著者:: Edwards, I, 等
出版事項: (2000)

Adverse drug reactions: keeping up to date.
著者:: Aronson, J, 等
出版事項: (2002)

Post-marketing drug withdrawals: pharmacovigilance success, regulatory problems : Arrêts de commercialisation de médicaments post-autorisation : succès de la pharmacovigilance, problèmes réglementaires
著者:: Aronson, J
出版事項: (2017)

Paradoxical reactions: Under-recognized adverse effects of drugs?
著者:: Hauben, M, 等
出版事項: (2006)

National differences in publishing papers on adverse drug reactions.
著者:: Ferner, R, 等
出版事項: (2005)

Distinguishing hazards and harms, adverse drug effects and adverse drug reactions : implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring.
著者:: Aronson, J
出版事項: (2013)

Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.
著者:: Loke, Y, 等
出版事項: (2006)

Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
著者:: Onakpoya, IJ, 等
出版事項: (2020)

Meyler's side effects of drugs : the international encyclopedia of adverse drug reactions and interactions /
著者:: Aronson, Jeffrey K.
出版事項: (2006)

Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability
著者:: Aronson, J
出版事項: (2012)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
著者:: Onakpoya, I, 等
出版事項: (2018)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
著者:: Talbot, J, 等
出版事項: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
著者:: Talbot, J, 等
出版事項: (2012)

Joining the DoTS: new approach to classifying adverse drug reactions.
著者:: Aronson, J, 等
出版事項: (2003)

Pharmacogenomics of cutaneous adverse drug reactions as implication for precision medicine
著者:: Chun-Bing Chen
出版事項: (2023-01-01)

Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
著者:: Smith, C, 等
出版事項: (1996)

Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.
著者:: Aronson, J
出版事項: (2005)

Adverse Drug Reactions of Cardiovascular Classes of Medicines—Data for Bulgarian Population
著者:: Zornitsa Mitkova, 等
出版事項: (2024-09-01)

Stephens' detection and evaluation of adverse drug reactions : principles and practice /
著者:: Talbot, J. C. C., 等
出版事項: (2012)

A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy.
著者:: McDowell, SE, 等
出版事項: (2013)

Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.
著者:: Aronson, J, 等
出版事項: (2010)

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
著者:: Derry, S, 等
出版事項: (2001)

Incomplete evidence: The inadequacy of databases in tracing published adverse drug reactions in clinical trials
著者:: Derry, S, 等
出版事項: (2001)

Lorcaserin in obesity: minimal benefits and ill-defined harms
著者:: Onakpoya, I, 等
出版事項: (2019)

Social Media as a Source of Information for the Detection of Adverse Drug Reactions in Post-Marketing Surveillance: A Review
著者:: E. K. Nezhurina, 等
出版事項: (2024-12-01)

Health risks of unknown medicines: evidence from adverse drug reactions in Laos
著者:: Caillet, C, 等
出版事項: (2016)

Control of adverse drug reactions in HIV/AIDS antiretroviral treatment with interchangeable medicines
著者:: M. V. Zhuravleva, 等
出版事項: (2018-02-01)

Adherence, adverse drug reactions, and discontinuation associated with adverse drug reactions of HIV post-exposure prophylaxis: a meta-analysis based on cohort studies
著者:: Shanshan Liu, 等
出版事項: (2023-12-01)

Nonsteroidal anti-inflammatory drugs’ adverse drug reactions: 10 years of national database data
著者:: G. I. Syraeva, 等
出版事項: (2022-02-01)

Characteristics of adverse reactions of three anti-glioma drugs in WHO-VigiAccess
著者:: Huadong Ke, 等
出版事項: (2024-10-01)